OBJECTIVE: To provide an update on the current knowledge of Asherman syndrome.
DESIGN: Literature review. SETTING: The worldwide reports of this disease. PATIENT (S) …

Background Surgical abortion by vacuum aspiration or dilatation and curettage has been the
method of choice for early pregnancy termination since the 1960s. Medical abortion became …

Background Clinical trials have established the high effectiveness and safety of medication
abortion in clinical settings. However, barriers to clinical abortion care have shifted most …

Misoprostol, a synthetic prostaglandin E1 analogue, is commonly used for medical abortion,
cervical priming, the management of miscarriage, induction of labor and the management of …

Background Medical abortion became an alternative method of pregnancy termination
following the development of prostaglandins and antiprogesterone in the 1970s and 1980s …

Background Miscarriage is a common complication encountered during pregnancy. It is
defined as spontaneous pregnancy loss before 20 weeks' gestation. Progesterone's …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

Background Medical abortion is under-used in developing countries. We assessed whether
early first-trimester medical abortion provided by midlevel providers (government-trained …

OBJECTIVE: To compare the pharmacokinetic profiles of orally, rectally, and vaginally
administered misoprostol tablets in pregnant women. METHODS: Women between 7 and 14 …

Objective This guideline reviews the evidence relating to the provision of first-trimester
medical induced abortion, including patient eligibility, counselling, and consent; evidence …